Kumquat Biosciences
Innovative oncology therapies translating breakthrough science into life-changing cancer treatments.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor | €0.0 | round |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
$70.0m | Late VC | ||
| Total Funding | 000k | ||
Related Content
Kumquat Biosciences is a biotechnology company dedicated to developing innovative therapies aimed at providing sustainable and life-changing benefits to cancer patients. The company focuses on translating breakthrough scientific discoveries into first-in-class therapeutics. Kumquat Biosciences operates in the oncology market, targeting cancer treatment and care. The business model revolves around drug discovery and development, leveraging the expertise of an accomplished team and distinguished scientific founders with a proven track record in oncology. Revenue is generated through the development and commercialization of proprietary cancer therapies, as well as potential partnerships and collaborations with other pharmaceutical companies. Kumquat Biosciences serves patients, healthcare providers, and the broader medical community by offering advanced treatment options that address unmet medical needs in oncology.
Keywords: oncology, cancer treatment, drug discovery, therapeutics, biotechnology, innovative therapies, breakthrough science, healthcare, pharmaceutical, oncology market.